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Abstract 
Purpose: The purpose of this project was to evaluate provider use of hemoglobin (HgA1c) 
measurement as a method of screening for Type Two Diabetes Mellitus (T2DM) per the 2015 
American Diabetes Association screening guidelines in a multidisciplinary primary care clinic in 
Kentucky.  
Methods: A retrospective electronic medical record review was conducted in a large ambulatory 
care clinic. A master list was compiled of all patients aged 45-89 years who were seen for any 
reason the first week of November 2015. A total of 127 records that met inclusion criteria were 
randomly selected. The proportion of patients who were appropriately screened in the past three 
years with HgA1c measurement was calculated. Data was analyzed using descriptive statistics.  
Results: Approximately 60% of all of the patients who met both the age and BMI screening 
criteria were screened in the past three years using HgA1c.  Of those patients who were screened, 
3.9% met criteria for the diagnosis of diabetes, and approximately 40% met criteria for the 
diagnosis of pre-diabetes based on the HgA1c results. 
Conclusions: Using only the HgA1c as a method of screening, providers in this clinic 
appropriately screened 60% of all patients who met the criteria of BMI and age which exceeds 
the projected compliance rate in the literature.    
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Introduction 
Type Two Diabetes Mellitus (T2DM) is a complex chronic illness that can have life-
threatening complications. This illness requires a partnership between the healthcare provider 
and the patient in order to manage the disease and prevent complications. There are several risk 
factors for diabetes. The two primary risk factors of obesity and age should be used to determine 
screening for diabetes. The American Diabetes Association (ADA, 2015) provides screening 
recommendations for diabetes using these two risk factors as indicators. Though a number of 
options for screening are available to providers, the HgA1c is the most comprehensive, reliable 
and easy to use screening test. Unfortunately, not all providers are screening based upon risk 
factors nor are they using the HgA1c to screen.  The purpose of this project is to evaluate 
provider compliance with the 2015 ADA screening guidelines in a multidisciplinary primary care 
clinic in Kentucky. 
Background 
 Diabetes is the seventh leading cause of death in the United States and affects 
approximately 23.6 million people. It is estimated 25 percent of Americans have diabetes but are 
undiagnosed and another 57 million are at increased risk for developing diabetes within a few 
years (U.S. Department of Health and Human Services [USDHHS], 2015). In 2012 the Centers 
for Disease Control and Prevention (CDC) noted the age-adjusted rate of adults diagnosed with 
diabetes in Kentucky has doubled from approximately four percent 1994 to approximately ten 
percent in 2012, a rate above the national average of nine percent during the same time period. 
The age-adjusted rate of adults with pre-diabetes in Kentucky of approximately eight percent 
was above the national average of seven percent as well (CDC, 2012).   
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There are several complications of diabetes. Per the U.S. Department of Health and 
Human Services (2015) diabetes can lower life expectancy by 15 years and increase the risk of 
heart disease two to fourfold. It is the leading cause of lower limb amputation, adult-onset 
blindness, and kidney failure. These complications may be prevented by early recognition of the 
disease, lifestyle modifications, and medication management (USDHHS, 2015; ADA, 2015; 
Chatterjee et al., 2010). 
The cost for medical care for patients with diabetes is substantial. In 2007, the financial 
burden of diabetes medical care was approximately $174 billion in the United States which 
included disability and premature death (USDHHS, 2015).  For Kentucky, the estimated cost of 
diabetes was over three billion dollars, which included direct and indirect medical costs and 
reduced productivity in 2015 (KY Department for Medicaid Services, 2015). Associated 
healthcare costs are expected to increase proportionately with the number of individuals 
diagnosed with diabetes and prediabetes.  
Screening for T2DM leads to earlier diagnosis and interventions to prevent progression of 
the disease and subsequent complications. Screening for diabetes using HgA1c (Chatterjee et al., 
2010) and fasting plasma glucose improves health outcomes (Hanna et al., 2012; The Diabetes 
Prevention Program Research Group, 2005) and is cost effective (Chatterjee et al., 2010). 
However, not all practitioners are using the same guidelines for screening (Sarkar, Lopez, Black 
& Schillinger, 2011; Kuntz et al., 2012; Serrano, Leiferman, & Dauber, 2007). Several respected 
organizations such as the ADA, Diabetes Prevention Program, US Preventive Services Task 
Force (USPSTF), American Heart Association, the American College of Physicians, the 
Endocrine Society, and the Veterans Health Administration, periodically publish 
recommendations for screening. In 2008, the USPSTF published recommendations for screening 
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individuals with hypertension as the only risk factor. In contrast, the ADA recommends 
screening based on multiple risk factors.  
Most organizations agree individuals greater than age 40 who are overweight or obese 
should be screened for T2DM at least every three years (DPP, 2005; Siu, 2015; ADA, 2015). 
Dall et al. (2014) suggested the use of the ADA screening guidelines detected significantly more 
individuals with prediabetes and diabetes than the USPSTF guidelines. Such stark 
inconsistencies in recommendations could lead to missed screening opportunities and delayed 
diagnoses. 
Recently the USPSTF published guidelines recommending screening every three years 
for all individuals ages 40-70 years who are overweight or obese (Siu, 2015). The ADA (2015) 
has no age limit for screening but recommends screening individuals 45 years or older who have 
a BMI of 25 or greater at least every three years. More frequent screening is recommended for 
individuals who have one or more risk factors including physical inactivity, ethnicity, past 
medical history, family medical history, and co-morbidities such as hypertension and 
hyperlipidemia (ADA, 2015).    
 Testing for diabetes can be done using either HgA1c level, fasting plasma glucose, or 2-
hour oral glucose tolerance test (ADA, 2015). The ADA (2015) guidelines state the HgA1c is 
preferred because of its convenience. It provides a more accurate idea of blood glucose control 
reflecting the preceding three months. It is not affected by acute factors such as illness, stress, or 
recent food consumption (ADA, 2015; Degling, Rock, & Rogers, 2011). Levels may be affected 
by characteristics of the individual including anemia, ethnicity, and age (ADA, 2015) 
 The diagnosis of diabetes or pre-diabetes can be established on the HgA1c result. Pre-
diabetes describes individuals at an increased risk for development of diabetes. It has been 
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suggested HgA1c values are strong predictors of progression to diabetes.  Per the ADA (2015), 
HgA1c values of 6.5% or greater are consistent with the diagnosis of diabetes. Hemoglobin A1C 
values of 5.7-6.4% are consistent with the diagnosis of pre-diabetes. Zhang et al. (2010) reported 
individuals with HgA1c values of 5.5-6.0% had up to a 25% chance and those with values of 6.0-
6.5% had up to a 50% chance of developing diabetes within five years.  
Purpose 
 The purpose of this project was to evaluate provider compliance with the 2015 ADA 
screening guidelines for T2DM using HgA1c measurements in a multidisciplinary primary care 
clinic in Kentucky. There were four objectives for this project. The primary objective of this 
study was to determine the proportion of patients 45-89 years of age at high risk for diabetes 
(BMI ≥ 25) who were screened for diabetes using HgA1c at or within the three years prior to the 
sampled visit. A second objective was to determine if patients were screened at acute problem 
visits or health maintenance visits. The third objective was to determine the number of acute and 
health maintenance visits in the past three years where screening could have been conducted if 
indicated. Lastly, this study aimed to determine whether or not patients who met screening 
criteria were screened, using HgA1c, more frequently than every three years.  
 Methods  
Study Design 
 This study was approved by the Institutional Review Board for Protection of Human 
Subjects at the University of Kentucky and by the internal research committee at the primary 
care clinic. A retrospective chart audit was conducted to determine whether patients who met 
inclusion criteria were screened using HgA1c measurements in the past three years. Patients met 
inclusion criteria if they were between 45-89 years old, had a BMI ≥25, and were seen the first 
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week of November 2015.  Patients were excluded if they had a previous diagnosis of diabetes 
mellitus type 1, diabetes mellitus type 2, pre-diabetes, gestational diabetes, impaired glucose 
tolerance, or impaired fasting glucose 
 A total of 565 patients over the age of 45 were seen during the study interval. Using the 
World Health Organization (2008) guide to choosing a sample size, for a population of 565 
patients, a sample of 127 patients was recommended for statistical significance. Data collected 
included patient demographics, credentials of the provider who appropriately ordered a HgA1c 
screening test, the HgA1c result, the visit type (acute or health maintenance), the number of 
“missed opportunities”, and whether or not the patient was screened more frequently than every 
three years (see Appendix A: Data Collection Table).  De-identified data was collected using an 
electronic data collection form (see Appendix A) and was stored using REDCap®, a secure, 
password protected web-based application.  
After receiving a master list of patients meeting inclusion criteria (age and BMI) who had 
been seen for an acute or health maintenance visit, every fourth chart was reviewed until the goal 
sample of 127 patients was met. Acute visits were included because this may be the only 
opportunity to screen patients who miss health maintenance visits. It is important to note at this 
clinic, providers practice under a team model. Each patient is assigned to a team consisting of an 
attending, two resident physicians, and one advanced practice registered nurse. The physicians 
are assigned as the primary care providers. However, the APRN is a vital part of the health care 
team, seeing mostly acute sick visits, chronic disease follow-ups, and initial disease specific 
visits for new patients. This model allows patients to be seen in a timely manner and improves 
access to care. 
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Data Analysis 
 Results from the retrospective electronic medical record review were analyzed using 
SPSS 22 statistical software. Initially, statistical significance between provider type and 
screening was anticipated. However, due to the distribution in numbers of the provider types in 
the sample, this relationship could not be adequately evaluated. Therefore, descriptive statistics 
including frequencies, means, and percentages were used to evaluate study objectives regarding 
screening practices.  
Results 
  Of the 595 patients who were seen during the first week of November 2015, 127 patients 
who met inclusion criteria were systematically selected. This sample had an average age of 59.1 
years old, with a range of 45-88 and a standard deviation of 9.6.  Sixty-one percent of the sample 
were females. The average BMI was 30.3 with a range of 25.0-43.6 and a standard deviation of 
4.2. Fifty-two percent of the patients in the sample were considered overweight (BMI 25.0-29.9), 
the remaining individuals were considered obese (BMI ≥ 30). 
Table 1. Summary of Diabetes Screening using HgA1c 
Variable n (%) 
Were patients who met criteria (N=127) 
screened?  
Yes 
No 
 
  
76 (60%) 
51 (40%) 
Visit type of those screened (n=76) 
Health Maintenance 
Acute  
 
68(90%) 
8(10%) 
Were patients screened more than every three 
years using HgA1c? 
Yes 
No 
           
 
23(30%) 
53(70%) 
A1c results of those screened (n=76): 
Diabetes (HgA1c ≥6.5%) 
Pre-diabetes (HgA1c 5.7-6.49%) 
Normal (HgA1c <5.7%) 
 
3(4%) 
30(40%) 
43(56%) 
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Approximately 60% (n=76) of the patients who met screening criteria were screened 
using HgA1c measurement. The majority of screening occurred during a health maintenance 
visit (n=68 or 90%). Of the health maintenance visits, 76% were with a physician. Acute visits 
only accounted for 10% of the screenings. Of the acute visits, 62% were with an APRN. 
Of those that were screened, approximately 40% met the diagnostic criteria of pre-
diabetes with HgA1c levels between 5.7 and 6.49%. Of those individuals with prediabetes, 57% 
were considered obese with a BMI of 30 or greater. There were three patients (4%) that met 
diagnostic criteria for diabetes with HgA1c levels of 6.5% or greater. Of those patients with 
diabetes, two thirds were obese.  
Approximately 40% (n=51) of the patients who met screening criteria were not screened 
using HgA1c measurement in the past three years. The individuals not screened had an average 
of five acute visits and four health maintenance visits within that three-year period.  Of those 
screened, 30% were screened more than once in the last three years.  
Discussion  
 In this setting more than half of patients meeting screening criteria were screened using 
HgA1c measurements. The proportion of patients screened by this clinic (60%) using HgA1c is 
higher than estimates in the literature of a 5-50% compliance rate for screening (Koll & Hewitt et 
al., 2011, Dall et al., 2012). The actual screening rate may be higher since only one of the three 
recommended screening tests was studied.  
Most of the patients were screened during a health maintenance visit which is considered 
standard practice. The majority of screening tests were ordered by physicians, which aligns with 
the practice model of this particular clinic, as APRNs are not assigned to patients as primary care 
providers and screening is not expected at acute visits. Initially there was interest in comparing 
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screening rates between providers, due to the distribution in this sample, this comparison was not 
possible.  Though the majority of screenings were conducted at health maintenance visits, it may 
be the case that acute visits are the only screening opportunities for some individuals.  
There are several reasons why patients do not come in for health maintenance visits 
which may include lack of time, resources, insurance, or motivation. Some individuals believe 
that they do not need to see a health care provider unless they are ill. Others may be unaware of 
the benefits of regular contact with a health care provider, such as screening, and the risks of not 
being seen regularly. Therefore, health care providers must capitalize on opportunities when they 
present themselves. Preventive services, such as screening, at acute problem visits are not ideal. 
Necessary and important information about why screening is indicated, the type of screening, 
possible outcomes, and follow up are diluted due to the limited allotted time. Also, patients may 
not be receptive to recommendations for screening because they are focused on the acute 
problem that brought them in. Research evaluating patient barriers to health maintenance visits 
and potential solutions is needed.     
Forty percent of the patients who met screening criteria had not been screened with 
HgA1c measurement in the past three years. The patients who were not screened presented to the 
clinic for five acute visits and four health maintenance visits, on average, over the past three 
years. They had an average of eight visits with a physician and one visit with an APRN in the 
past three years. These findings suggest that physicians had more interaction with the patients 
who were not screened with HgA1c measurements. However, the provider may have screened 
the patient using fasting plasma glucose as part of routine laboratory testing.  
 Approximately 30% of patients who were screened in this study had been screened more 
than once in the past three years. This specific data was collected at the request of the clinic to 
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determine whether they were screening patients inappropriately, or more often than the 
recommended three-year interval. Though the ADA (2015) discouraged screening more than 
every three years, there may be indications for retesting such as the development of new risk 
factors or previous testing that indicated increased risk. For instance, if the patient was newly 
diagnosed with hypertension or hyperlipidemia, screening would be indicated. Also, if a patient 
presents with symptoms such as blurred vision, frequent urinary tract infections, frequent yeast 
infections, or numbness or tingling of the extremities, screening for diabetes would be indicated 
as part of the diagnostic workup. Since this study focused on BMI and age as primary risk 
factors, it may not be sufficient in determining screening too frequently because other risk 
factors were not considered.  
 Pre-diabetes was noted in 40% of the patients screened in this study. This is consistent 
with the national average of 35-50% of adults having pre-diabetes, validating screening 
individuals who have risk factors for diabetes (CDC, 2011).  Of those patients with prediabetes, 
only 57% were considered obese. Of the three patients identified as having diabetes, only two 
thirds had a BMI of 30 or greater. Once individuals are screened appropriately, interventions can 
be implemented to decrease the progression of pre-diabetes to diabetes. 
Limitations 
 A major limitation of this study was the evaluation of the HgA1c as a screening method. 
Though 40 percent of patients meeting the inclusion criteria were not screened, it is possible that 
providers used a fasting glucose test which is part of the metabolic profile typically ordered. 
However, in the electronic medical record used for this study, it was difficult to determine 
whether or not the patient was fasting for these routine labs. The HgA1c measurement was the 
only diabetes screening test evaluated because it is the most accurate and specific to diabetes. 
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Therefore, this study may not adequately portray overall screening practices or compliance with 
the screening guidelines.  
 There were other limitations of this study because of the design. This study did not 
evaluate screening or rescreening based on risk factors other than age and BMI. Secondly, the 
original objective to compare screening practices by provider type was not met because the 
patients were not divided evenly by provider. Also, the practice model of the clinic setting was 
not conducive to comparisons of providers as APRNs are not assigned as PCPs. Lastly, this 
study did not get provider input on preferred screening method (i.e. fasting plasma glucose 
versus HgA1c) which could have explained the individuals who were not screened using HgA1c. 
Implications for Practice 
 Though the ADA has clear definitions of when and how to screen, provider compliance 
with screening guidelines could use improvement. The ADA (2015) recommends HgA1c as the 
screening test of choice as it is convenient and unaffected by fasting status. Also, the HgA1c is 
specific to diabetes. When a provider orders this measurement, they are intentionally looking for 
the presence of diabetes. Clearly, it appears that it should be the only test recommended to screen 
for diabetes in the future.  
 Since the ADA updates recommendations for screening and diagnosing diabetes 
annually, a formal educational session to review the latest updates may be useful in this and 
other primary care clinics. It may also be beneficial to educate the public about risk factors for 
diabetes, the importance of early detection, and available screening methods. Evaluation of 
current procedures once a patient is diagnosed with diabetes or prediabetes would be helpful in 
determining appropriate use of evidence-based interventions such as healthy diet, regular 
physical activity, and weight loss. 
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Finally, several other quality improvement questions need to be answered and evaluated. 
The pros, cons, and barriers to screening at acute versus health maintenance visits should be 
explored. Analysis of rescreening practices and whether they are cost effective would be useful 
to improve current standards of care.  Determining what processes and procedures are in place 
once a provider receives results of screening tests would be helpful to ensure adequate follow up 
and timely intervention. Barriers to compliance with screening guidelines and interventions to 
improve compliance should be assessed as well.  
Conclusion 
In conclusion, diabetes is a major health issue in the United States which warrants 
attention by every health provider. Screening for diabetes using an evidence-based protocol, such 
as one published by the ADA, can lead to early diagnosis of diabetes and pre-diabetes. 
Identification of individuals at risk for diabetes is essential for early intervention and prevention 
of progression of the disease and/or complications. Despite provider adherence to the 2015 ADA 
guidelines at this clinic, was approximately 60% and above national norms of 5-50% for all 
screening methods, a significant percentage of patients had not been screened. Since early 
detection and intervention can positively affect quality of life and health outcomes for patients, 
there is reason to strive for even more improvement. 
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Appendix A 
Data Collection Table 
Patient # Age BMI 
reading 
at this 
visit 
Gender Was 
HgA1C 
ordered 
since 
turning 
45 (or 
in the 
past 3 
years) 
Age of 
the 
patient 
when 
HgA1C 
ordered 
Has 
patient 
been 
screened 
more 
often 
than 
every 3 
years? 
Acute 
or 
HM 
visit? 
Hg 
A1C 
result 
Provider 
type 
when 
HgA1C 
ordered 
Total 
number 
of acute 
visits in 
the past 
3 years 
when no 
HgA1c 
done for 
diagnosis 
Total 
number 
of HM 
visits in 
the past 
3 years 
when no 
HgA1c 
done for 
diagnosis 
Number 
of visits 
with 
APRN  
in the 
past 3 
years 
when no 
HgA1c 
done for 
diagnosis 
Number of 
visits with 
MD in the 
past 3 years 
when no 
HgA1c done 
for diagnosis 
              
1              
2              
3              
4              
5              
6              
7              
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